Clinical pathologic subtypes, age, tumor location, histological grade, lymph node metastasis, and molecular phenotype expression (ER, PR, HER-2, Ki-67, CK5/6, E-cad, P63, and P120) were compared across all subgroups. This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.